Q1 2024 X4 Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to X4 Pharmaceuticals first-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr. Dan Ferry from LifeSci Advisors. Thank you, Mr. Ferry. You may begin.
Thank you, operator, and good morning everyone. Thank you for joining us today. Presenting on todayâs call will be Dr. Paula Ragan; X4âs President and CEO; and the companyâs Chief Financial Officer, Adam Mostafa. Following prepared remarks, we will open up the call to your questions, and weâll be joined by Chief Commercial Officer, Mark Baldry; Chief Medical Officer, Dr. Christophe Arbet-Engels; Chief Operating Officer, Mary DiBiase; Chief Scientific Officer, Art Taveras; and Jose Juves, Head of Corporate and Patient Affairs
As a reminder, on todayâs call, the company will be making forward-looking statements regarding regulatory and product development and commercialization plans as well as research
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |